Esperion Therapeutics, Inc (ESPR) insider trading
Every open-market stock purchase and sale by Esperion Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $576K over the last 12 months (10 sales). No open-market buys.
- Last insider buy: J Martin Carroll (Director), $36.3K, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $576K (10 sales). Last close $3.18 on Jul 10, 2026.
Recent ESPR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 13, 2026 | Sheldon L. Koenig (CEO) | Sold (not open market) | $1.6M |
| Jul 13, 2026 | Sheldon L. Koenig (CEO) | Sold (not open market) | $1.3M |
| Jul 13, 2026 | Sheldon L. Koenig (CEO) | Sold (not open market) | $1.1M |
| Jul 13, 2026 | Benjamin Looker (C-suite exec) | Sold (not open market) | $657K |
| Jul 13, 2026 | Benjamin Halladay (CFO) | Sold (not open market) | $540K |
| Jul 13, 2026 | Benjamin Halladay (CFO) | Sold (not open market) | $410K |
| Jul 13, 2026 | Benjamin Halladay (CFO) | Sold (not open market) | $320K |
| Jul 13, 2026 | Benjamin Looker (C-suite exec) | Sold (not open market) | $308K |
| Jul 13, 2026 | Benjamin Looker (C-suite exec) | Sold (not open market) | $302K |
| Jul 13, 2026 | J Martin Carroll (Director) | Sold (not open market) | $73.1K |
| Jul 13, 2026 | Seth H. Z. Fischer (Director) | Sold (not open market) | $73.1K |
| Jul 13, 2026 | Jay Shepard (Director) | Sold (not open market) | $73.1K |
| Jul 13, 2026 | Robert E. Hoffman (Director) | Sold (not open market) | $56.4K |
| Jul 13, 2026 | John Craig Thompson (Director) | Sold (not open market) | $40K |
| Jul 13, 2026 | Jay Shepard (Director) | Sold (not open market) | $38.3K |
| Jul 13, 2026 | Seth H. Z. Fischer (Director) | Sold (not open market) | $38.3K |
| Jul 13, 2026 | J Martin Carroll (Director) | Sold (not open market) | $38.3K |
| Jul 13, 2026 | J Martin Carroll (Director) | Sold (not open market) | $28.8K |
| Jul 13, 2026 | Seth H. Z. Fischer (Director) | Sold (not open market) | $28.8K |
| Jul 13, 2026 | Jay Shepard (Director) | Sold (not open market) | $28.8K |
| Jul 13, 2026 | Robert E. Hoffman (Director) | Sold (not open market) | $6.1K |
| Jul 13, 2026 | Robert E. Hoffman (Director) | Sold (not open market) | — |
| Jul 13, 2026 | J Martin Carroll (Director) | Sold (not open market) | — |
| Jul 13, 2026 | Jay Shepard (Director) | Sold (not open market) | — |
| Jul 13, 2026 | Seth H. Z. Fischer (Director) | Sold (not open market) | — |
Who's trading ESPR
- J Martin Carroll, Director: other filings, last Jul 13, 2026
- Seth H. Z. Fischer, Director: other filings, last Jul 13, 2026
- Benjamin Halladay, CFO: sold $78.3K (3 sales), last Jul 13, 2026
- John B. Harlow Jr., C-suite exec: other filings, last Jul 13, 2026
- Robert E. Hoffman, Director: other filings, last Jul 13, 2026
- Sheldon L. Koenig, CEO: sold $416K (3 sales), last Jul 13, 2026
- Benjamin Looker, General Counsel: sold $81.5K (4 sales), last Jul 13, 2026
- Jay Shepard, Director: other filings, last Jul 13, 2026
- John Craig Thompson, Director: other filings, last Jul 13, 2026
Get free alerts when an insider at Esperion Therapeutics, Inc files a new trade →